MYNZ (MYNZ)
Mainz Biomed B.V.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
DEMainz Biomed B.V. is a German company specializing in molecular genetics for the development of cancer diagnostics.
The firm engineers both in-vitro diagnostic (IVD) tools and assays designed exclusively for research, primarily catering to clinical applications within human genetics. Among its key offerings is ColoAlert, a screening test for detecting colorectal cancer.
Additionally, they are developing PancAlert, a promising product candidate intended for pancreatic cancer screening. Beyond cancer, Mainz Biomed also provides GenoStrip, a molecular genetic solution for identifying pathogens in various environments. Established in 2008, the company maintains its headquarters in Mainz, Germany.
Leadership
Christopher Von Toerne
Chief Operating Officer
Guido Baechler
Chief Executive Officer & Executive Director
Stefan Erlach
Head of Human Resources
William J. Caragol
Chief Financial Officer & Senior Vice President
Employees
19
Country
DE
Sector
Healthcare
Website
mainzbiomed.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 NATAN DAVID | Director | Grant/Award | 137.1K | -- | May 8, 2026 |
 Ben-Tzvi Avraham | Director | Grant/Award | 137.1K | -- | May 8, 2026 |
 Lazar David E. | Chief Executive Officer | Grant/Award | 1.00M | $1.50M | Apr 22, 2026 |
| Lazar David E. | Chief Executive Officer | Grant/Award | 1.00M | $1.50M | Apr 22, 2026 |
| Lazar David E. | Chief Executive Officer | Grant/Award | 1.00M | -- | Feb 13, 2026 |
| Lazar David E. | Chief Executive Officer | Grant/Award | 1.00M | -- | Feb 13, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
Lazar David E. · may incl. warrants· filed Aug 2026 | 477.0M | 94.3% | 13D |
Donahue Kevin Michael · may incl. warrants· filed Jan 2026 | 685.0K | 10.7% | 13G |
 BAECHLER GUIDO Chief Executive Officer, Director | 605.1K | -- | FORM 4 |
Armistice Capital, LLC · filed Feb 2026 | 435.1K | 5.0% | 13G |
 Caragol William J Chief Financial Officer | 367.9K | -- | FORM 4 |
 Ben-Tzvi Avraham Director | 252.0K | -- | FORM 4 |
 NATAN DAVID Director | 137.1K | -- | FORM 4 |
JANE STREET GROUP, LLC | 84.6K | -- | 13F |
 Dreismann Heinrich Director | 64.7K | -- | FORM 4 |
 Tibbitts Gregory J Director | 55.9K | -- | FORM 4 |
Insiders
- NATAN DAVIDDirector
- Ben-Tzvi AvrahamDirector
- Lazar David E.Chief Executive Officer
- Caragol William JChief Financial Officer
- Dreismann HeinrichDirector
- Tibbitts Gregory JDirector
- BAECHLER GUIDOChief Executive Officer
- Donahue Kevin Michael10% Owner
- Hekland HansDirector
DE30d Avg
--
60d Avg
--
90d Avg
--